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Background: Patients making important medical decisions need to evaluate complex information in the light of
their own beliefs, attitudes and priorities. The process can be considered in terms of the theory of planned
behaviour.
Decision support technologies aim at helping patients making informed treatment choices. Instruments assessing
informed choices need to include risk knowledge, attitude (towards therapy) and actual uptake. However,
mechanisms by which decision support achieves its goals are poorly understood.
Our aim was therefore to develop and validate an instrument modeling the process of multiple sclerosis (MS)
patients’ decision making about whether to undergo disease modifying (immuno-)therapies (DMT).
Methods: We constructed a 30-item patient administered questionnaire to access the elaboration of decisions
about DMT in MS according to the theory of planned behaviour. MS-patients’ belief composites regarding
immunotherapy were classified according to the domains “attitude”, “subjective social norm” and “control beliefs”
and within each domain to either “expectations” or “values” yielding 6 sub-domains. A randomized controlled trial
(n = 192) evaluating an evidence based educational intervention tested the instrument’s predictive power regarding
intention to use immunotherapy and its sensitivity to the intervention.
Results: The psychometric properties of the questionnaire were satisfactory (mean item difficulty 62, mean SD 0.9,
range 0–3). Responses explain up to 68% of the variability in the intention to use DMT was explained by up to 68% in
the total sample. Four weeks after an educational intervention, predictive power was higher in the intervention (IG)
compared to the control group (CG) (intention estimate: CG 56% / IG 69%, p= .179; three domains CG 56% / IG 74%,
p= .047; six sub-domains CG 64% / IG 78%, p = .073). The IG held more critical beliefs towards immunotherapy
(p= .002) and were less willing to comply with social norm (p= .012).
Conclusions: The questionnaire seems to provide a valid way of explaining patients’ inherent decision processes and
to be sensitive towards varying levels of elaboration. Similar tools based on the theory of planned behaviour could be
applied to other decision making scenarios.* Correspondence: k@sper.info
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Quality of decisions in health care is increasingly viewed as
sensitive to individual factors such as preferences and
beliefs which on the level of groups and of populations are
very difficult to determine [1,2]. Since concrete choices re-
veal little about decision quality, the process of making a
decision might be a better quality indicator [3-5]. This
process is predominantly performed internally and includes
negotiating information about possible benefit and side-
effects with preferences, values and risk attitudes [6]. As
therefore, quality refers to both highly individual and intra-
personal criteria, the challenge of assessment is obvious.
Accordingly, an ideal decision making process would mean
implying cognitive and emotional appraisal of relevant in-
formation with anticipated related consequences [7,8]. The
latter has been defined as “informed decision” which can be
considered as meeting two conditions: first, the patient
should have processed the relevant risk knowledge and sec-
ond, the choice should reflect the patient’s values [6]. Based
on this definition, the Multimodal Measure of Informed
Choice (MMIC) [3] has been used as an endpoint for stud-
ies on decision support. The MMIC comprises three di-
chotomous measures, knowledge (good, poor), value
(positive, negative) and choice (uptake or non-uptake of the
intervention under consideration) leading to eight types of
choices Only two of these indicate informed choice: either
an informed patient’s values are in favour of the interven-
tion which is applied by the patient, or an informed
patient’s values are against the intervention which is
rejected. Marteau et al. define value as a basic attitude,
which referring to Ajzen is a person’s overall evaluation of
the behaviour in question [9]. However, the process of deci-
sions and the mechanisms or moderators by which attitude
impacts on behaviour cannot be derived from MMIC,
which merely assesses the result of this process. Other
intrapersonal characteristics also influence the decision
making process [10]. Furthermore, different internal consid-
erations – such as beliefs about the consequences of an ac-
tion or the individual’s own ability to control the situation -
can lead to the same choices. Frequencies of informed
choice decisions measured using Marteau’s method do not
explain how they were achieved.
Elaboration of health related decisions i.e. the motiv-
ational process an individual goes through when anticipat-
ing an action - the so called action regulation - are seen as
internal cognitive processes by a group of theories such as
the health belief model, the social–cognitive theory, the
theory of reasoned action, the theory of planned behaviour
(TPB) and the protection motivation theory [11]. These
theories share the assumption that each behaviour is pre-
dominantly a function of attitudes and beliefs, as well as
expectations of future events and outcomes. Facing vari-
ous alternatives, individuals will choose the action most
likely leading to positive outcomes. Among these theories,the TPB [9] is one of the best proven to explain a specific
health behaviour by a set of domains in a wide number of
research areas [12-14]. Prediction of self-reported behav-
iour is superior to observed behaviour. However, accord-
ing to the literature TPB is capable of explaining 20% of
the variance in prospective measures of actual behaviour
(and 27 to 39% of intention) [15-18].
The TBP postulates three conceptually independent
domains determining an intention to perform a specific be-
haviour: "attitude" refers to the degree to which a person
has a favourable or unfavourable appraisal of the behaviour
in question; "social norm" refers to the perceived social
pressure to perform/not perform the behaviour; "perceived
behaviour control" refers to the perceived ease or difficulty
of performing the behaviour and is assumed to reflect past
experiences as well as anticipated impediments and obsta-
cles. The theory is based on the expectancy-value model,
assuming that overall evaluation of decisional options often
contains two separable sub-domains: an expected outcome
and a given value [7]. For example, the subjective value of a
given outcome such as reduction of the number of relapses
in multiple sclerosis as the benefit from disease modifying
treatment (DMT) affects the attitude in direct proportion
to the strength of the belief regarding occurrence of this
outcome. A patient might be convinced of the efficacy of
DMT regarding reduction of relapse rates but on the other
hand might not prioritize this goal against others leading to
low impact of this belief on this patient’s attitude. As a gen-
eral rule, the more favourable the attitude and subjective
norm with respect to a specific behaviour and the greater
the perceived behavioural control the stronger is an indivi-
dual’s intention to perform the behaviour under consider-
ation. The relative weight by which the three domains
(attitude, subjective social norm, perceived behavioural con-
trol) impact on the intention is expected to vary across dif-
ferent behaviours and contexts.
Since, although not conclusive, the evidence for the
TPB’s validity to a broad variety of behavioural decisions
is promising, we choose the model to validate theoretical
assumptions underpinning our developments of decision
support strategies for patients with multiple sclerosis
[19-21].
Multiple sclerosis (MS) is a chronic-progressive disease
of young adults with a presumed autoimmune aetiology
[22]. People affected by the diseases have to deal with pro-
nounced uncertainty regarding prognosis and also regard-
ing effectiveness of available treatments. Hitherto, no
curative treatment exists. However, appearance of new
relapses, new lesions on magnetic resonance imaging and
progression of disability can be slowed down by DMT but
at the risk of side effects that can be long lasting and some-
time serious [19]. Therefore, decisions about disease modi-
fying treatments (DMT) are highly sensitive to patient
preferences [23]. In addition, MS patients claim active
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higher than in other diseases [24,25].
This paper describes development and validation of
the questionnaire “Planned behaviour in MS” (PBMS), a
patient-reported instrument assessing the process of deci-
sion making about DMT. By improving understanding of
processes underlying patients’ choices on DMT as well as
improving understanding of mechanisms mediating effects
of decision support strategies, we aim at tailoring decision
aids and other support strategies more to patients’ needs.
Methods
Ethics statement
The study protocol was approved by the ethics committee
of the Hamburg Chamber of Physicians (ref: PV3164) on
12th March 2009 All participants gave written informed
consent for recording, analysis and publication of their
data collected within this study.
Questionnaire concept and development
The development of the PBMS - a questionnaire intended
to predict or explain patient choices to use or not to use
DMT - was based on the instructions given by Ajzen [26].
We focused on assessing all relevant cognitive and emo-
tional issues (belief composites) presumably processed by
MS-patients considering a decision about DMT. The ori-
ginal pool of about 120 belief composites was generated by
extracting salient statements from 80 videos of physician-
patient consultations on DMT decisions [19]. StatementsIntentionBehaviour
Figure 1 Illustration of theory of planned behaviour, I Ajzen [9].identified as relevant were classified according to their
underlying constructs in terms of the TPB framework. They
were allocated to one of the three domains (attitude, sub-
jective social norm, perceived behaviour control) and then
within each domain to one of two sub-domains (expecta-
tions and values) (Figure 1). For example, a recently diag-
nosed MS patient might be convinced (attitude) that early
MS treatment in general is beneficial (expectation) while
assigning higher value to potential side effects (value). State-
ments were identified for all components of the TPB.
However, few statements related to control beliefs and in
particular assumed power of control. This pool of belief
composites and their allocation were discussed and supple-
mented by an expert panel of neurologists (CH, NS), health
scientists (SK, IB) and a psychologist (JK) all experienced in
MS treatment decision-making. During this process, classi-
fication of the statements was checked and about 20 new
statements were added from physicians’ clinical practice. In
the next step, based on the underlying concept items were
created to exhaustively cover the TPB framework for the
scenario of decision making on DMTs. With regard to
uniqueness, similarity and disjunctiveness, 38 items were
selected and piloted with 10 MS patients in the MS out-
patient clinic to check comprehensibility and relevance.
The final questionnaire consisted of 30 items including
three cumulatively constructed scales for the TPB domains
and six sub-domains accordingly: domain 1: Attitude, 12
items ((1a) 5 items assessing “Expectations regarding out-
comes of DMT” and (1b) 7 items assessing “SubjectiveExpectations regarding 











the attitudes of important 
referent individuals or 
groups as the person’s 
spouse, family, friends, 
doctor towards the target 
behaviour
Subjective value of the 
perceived social norm and 
the person’s motivation to 
comply with these norms 
Expectations regarding
the presence of  factors 
that may facilitate or 
impede performance of a 
behaviour
Subjective value of each 
factor and the perceived 
power of these factors
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norms, 10 items ((2a) 4 items assessing “Expectations
regarding attitudes of important reference individuals or
groups” and (2b) 6 items assessing “Subjective value of per-
ceived social norm and the person’s motivation to comply
with these norms”), and domain 3: Control beliefs, 8 items
((3a) 4 items assessing “Expectations regarding the presence
of factors that may facilitate or impede successful DMT”
and (3b) 4 items assessing “Subjective values and perceived
power of these factors”) (Additional file 1). Items were for-
mulated as statements to be answered by specifying one’s
extent of agreement on a four-point Likert scale (I dis-
agree/I somewhat disagree/I somewhat agree/I agree).
Within each scale the numbers of items in favour of and
against DMT were balanced. Items from the three scales
were mixed in the questionnaire (Additional file 1).
Pre-testing
Psychometric properties of the PBMS, in particular item
difficulties and variance, were investigated in a sample of
50 MS patients with relapsing-remitting disease from
the MS out patient clinic at the University Medical
Centre. Of these, 34 participated in the pilot phase of a
4-hour patient education programme about diagnosis,
prognosis and early treatment of multiple sclerosis
(PEPADIP, ISRCTN12440282) [27]. To allow for ex-
ploratory construct validation, risk knowledge (19 items),
DMT status and actual intention to use DMT were also
assessed. Patients participating in PEPADIP piloting
completed the PBMS questionnaire twice, i.e. before and
after the education program.
We assumed that the predictive power of the PBMS
regarding intentions to use DMT would be comparable to
results for similar TBP-based approaches in the literature
[15-18]. Additionally, exploration of the validity of the PBMS
addressed its ability to discriminate sub-groups of patients
with different DMT status (currently on / not yet on DMT),
on different levels in relation to the educational programme
(before / after) and regarding risk knowledge (high / low).
Validation study
The PBMS was employed in 192 relapsing-remitting MS
patients participating in a randomised controlled trial to
evaluate the effectiveness of the educational programme
PEPADIP [27]. The aim of the program was to enhance
critical reflection on scientific evidence and on patients’
own values and preferences and so to enable them to
make more informed choices on DMT. Patients com-
pleted the PBMS 2 weeks before and 2 weeks after the
intervention. As the control group did not receive any
specific intervention we considered this subsample ap-
propriate to estimate PBMS re-test-reliability. Besides
demographic and general variables, and the patient’s actual
intention to start DMT (patient self-administered yes/noreply to a single question), we recorded DMT risk know-
ledge (patient self-administered 19 item questionnaire)
based on an earlier multiple-choice questionnaire [24].
The construct validity of the PBMS was addressed as
follows. First, we compared the study groups’ decision
making processes on the level of absolute PBMS score
values. We assumed the intervention to lead to more
critical reflection on DMT (attitude), less willing to com-
ply with the opinions of powerful others (subjective so-
cial norm) and greater self-efficacy (perceived control
beliefs) compared to the control group. Secondly, based
on our assumption that the PBMS-model fit reflects the
depth of elaboration of the decision, we compared the
study groups regarding the predictive power of the
PBMS towards the intention to use DMT. In the same
regard we compared patients with high and low risk
knowledge and patients already using with those not yet
using DMT. Thirdly, as the proportional power of the
influence of three PBMS domains on a particular target
behaviour might vary [26], we explored the effect of the
educational intervention on the relative impact of the
three domains. We hypothesized that the influence of
the social norm would decrease in favour of control
beliefs as a result of the intervention.
Data analysis
After reversing polarity of the data from negatively poled
items, mean scores were calculated for all 6 subscales
(range 0–3). PBMS item difficulties between 0.6 and 2.5 (i.
e. values within two thirds of the scale range) and standard
deviations higher than 0.5 (i.e. half a scale step) were
defined as satisfactory. Two levels of risk knowledge (high
and low risk knowledge, high, low RK) ) were defined by
median split based on the mean DMT risk knowledge
score, to produce two groups of comparable size.
According to the expectation-value model, and in par-
ticular to the TBP model’s structure, subscale mean values
were multiplied pair-wise within each of the three main
domains [26]. While the proportion by which the three
domains impact on the intention can vary between different
behaviours [26], no assumption was available to define spe-
cific proportions for the concrete decision-making scenario.
An “ intention estimate coefficient” was therefore defined
by simply calculating the sum of the three domains’ mean
values so that equal weight was given to attitude, subjective
social norm and control beliefs (Table 1).
Linear regression analyses were conducted according to
the model’s structure (Figure 1) which, for the target cri-
terion intention to use DMT (dependent variable), implies
three possible sets of predictors (independent variables):
(1) the intention estimate (one predictor), (2) the three
domains: attitude, subjective social norm and perceived
behavioural beliefs, (three predictors) (3) the six sub-
domains (six predictors). Simple linear regressions were
Table 1 Effects of educational intervention on PBMS
parameters (validation trial)
PBMS Comparison of PBMS parameters
between study groups
Domains control intervention range p
Sub-domains
1 Attitude 3.5 (1.9) 3.0 (1.8) 0-9 .04*
a: expectations regarding outcomes 1.8 (0.6) 1.6 (0.6) 0-3 .001*
b: values of expected outcomes 1.8 (0.6) 1.8 (0.6) 0-3 .55
2 Social norm 2.1 (1.2) 1.7 (1.0) 0-9 .006*
a: assumed attitudes of
important others
1.9 (0.6) 1.8 (0.7) 0-3 .28
b: motivation to comply with
these norms
1.1 (0.4) 1.0 (0.4) 0-3 .004*
3 Control beliefs 3.2 (2.1) 2.9 (2.1) 0-9 .313
a: assumed facilitators or barriers 1.6 (0.7) 1.4 (0.8) 0-3 .14
b: perceived power of these factors 1.8 (0.6) 1.7 (0.7) 0-3 .42
Intention estimate 8.9 (4.1) 7.5 (4.4) 0-27 .04*
P-values refer to unpaired t-tests comparing post intervention mean scores of
intervention- and control groups. Theoretical range of scores is 0 to 3 for
sub-domains, 0 to 9 for domains and 0 to 27 for intention estimate. “*”
indicates statistically significant unpaired t-tests.
Kasper et al. BMC Medical Informatics and Decision Making 2012, 12:60 Page 5 of 9
http://www.biomedcentral.com/1472-6947/12/60conducted for each of the 3 predictor sets. R-squares indi-
cated the extent to which intention was explained by the
particular predictor set. Comparisons between R-squares
of subgroups were conducted using Fisher’s-Z-tests. Pre-
post correlations of PBMS scores (at item-, sub-domain
and domain-level) within the control group were calcu-
lated using Pearson coefficients.Results
Pre-testing
Item difficulties and standard deviations for the PBMS were
overall satisfactory (mean 1.6, empiric range 0.24 to 2.4;
mean SD 0.92, range 0.92 to 0.5). All but three items
showed satisfactory item difficulty and variability of itemTable 2 Predictive power of PBMS (Pre-test and RCT)
Sample Measure-ment Outcome
point i
pre total n = 50 r2
Pre-test pre sub s. n = 19 r2
post sub s. n = 19 r2
pre total n = 177 r2
RCT post total n = 177 r2
post CG n= 88 r2
post IG n = 89 r2
The table shows R-square(corrected R-square) values (indicating the percentage of
modifying therapy) using various predictor sets drawn from the PBMS in regression
includes participants of the PEPADIP pilot course who completed the PBMS twice (presponses was higher than 0.5 in all items. The PBMS
explained 55% of the criterion’s (intention to use or not use
DMT) variance when calculated based on the intention es-
timate (one predictor) and even more, when intention was
predicted based on the three domains (60%) or based on
the six mean scores of the sub domains (69%) (Table 2).
Patients not using DMT differed in their responses
regarding all but one sub-domain from DMT users whose
attitudes and control beliefs were more in favour of DMT
(attitude without DMT 2.1, with DMT 4.6, p< .01; control
beliefs without DMT 1.6, with DMT 4.7, p< .01) (Table 3).
Better risk knowledge was associated with more critical
beliefs about possible outcomes of DMT and stronger
beliefs in control abilities (domain1a: highRK 1.22, lowRK
1.73, p= .009; domain3a: highRK: 1.4, lowRK 1.9, p= .016,
range 0–3). Regardless of the predictor set (intention esti-
mate, 3 domains or six sub-domains) predictions based on
PBMS after the programme were significantly better than
before (before 34 to 56%, after 65 to 73% explained vari-
ance, p=<.01) (Table 2).Validation study
In the RCT, 192 MS patients were randomly allocated to
the control (99) or the intervention group (93). The two
groups were comparable with respect to demographic and
disease related characteristics (Table 4). Results of PBMS
validation are based on 177(88/89) datasets at baseline
and 174 (88/86) datasets at follow-up within a 4 week
time-frame. All datasets included were complete.
Pre-post correlations within the control group were low
on the item level (0.52, range: 0.13 to 0.76) and moderate
on the level of sub-domains (0.65, range: 0.57 to 0.73). Con-
trary to our assumptions, belief composites had changed
even in the control group (Table 2). Therefore, interpret-
ation of re-test -reliabilities no longer seemed appropriate.
Regarding absolute PBMS score levels, all single and
composed PBMS -parameters of the control group pointedPBMS predictor set
ntention estimate domains sub-domains








explained variance) from predicting the criterion intention to use DMT (disease
analyses.”*” = significance level <0.01. The pre-test sub sample (n = 19)
re & post). RCT=randomized controlled trial.
Table 3 Exploration of discriminatory validity using DMT
status (pre-test) (N =50)
PBMS DMT status








1: Attitude 2.1 / 4.6 2.4 / 4.1 0-9 <.01<.01
a: expectations regarding outcomes 1.4 / 2.0 1.5 / 1.9 0-3 <.01<.01
b: values of expected outcomes 1.4 / 2.2 1.5 / 2.1 0-3 <.01<.01
2: Social norm 1.2 / 1.8 1.5 / 2.4 0-9 .23<.01
a: assumed attitudes of important
others
1.2 / 2.0 1.5 / 2.2 0-3 <.01<.01
b: motivation to comply with these
norms
1.0 / .9 1.0 / 1.1 0-3 <.01 .34
3: Control beliefs 1.6 / 4.7 2.1 / 4.1 0-9 <.01<.01
a: assumed facilitators or barriers 1.0 / 2.1 1.2 / 1.9 0-3 <.01<.01
b: perceived power of these factors 1.4 / 2.2 1.5 / 2.0 0-3 <.01<.01
Intention estimate 4.8 / 11.1 6.0 / 10.1 0-27 <.01<.01
PBMS results are provided as means separately for groups using or not using
DMT (disease modifying treatment), pre-test participants of (N = 50) and
participants included in the randomized controlled trial (RCTN = 177). P values
refer to unpaired t-tests comparing the two groups.
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intervention group. This consistent pattern was statistically
significant for the intention estimate (IG 7.5, CG 8.9,
p= .04) as well as for attitude and subjective social norm
showing that patients in the intervention group held more
critical beliefs towards DMT (domain1: IG 3.0, CG 3.5,
p= .004; domain1a: IG 1.8, CG 1.6, p= .001) and were less
willing to comply with perceived social norms regarding
DMT (domain2: IG 1.7, CG 2.1, p= .006; domain2b: IG 1.0,
CG 1.1, p = .004) (Table 1). The sensitivity of the PBMS
questionnaire for actual DMT intentions was reflected in
differences regarding PBMS scores between participants
using and not yet using DMT. Patients already using DMT
were more in favour of DMT in five of six sub-domains
(Table 3). Results for the sensitivity of the PBMS to
the level of risk knowledge differed slightly from those in
pre-tests: No effect was seen regarding control beliefs





control intervention total P*
Female (%) 35 (70) 74 (75) 70 (75) 144 (75) .93
Age (SD) 41 (9) 37 (10) 36 (11) 36 (11) .61
Years since
diagnosis (SD)
5 (6) 2 (1) 2 (1) 2 (1) .16
Ongoing DMT (%) 32 (64) 55 (56) 51 (55) 106 (56) .98
Values are frequencies (percentages) and means (SD). *P values refer to either
chi-square tests or to unpaired t-tests. DMT = disease modifying treatment,
RCT = randomized controlled trial.knowledge held more critical beliefs (domain1a 1.8 range
0–3) and were less motivated to comply with assumed
norms of important others (domain2b: .89; range 0–3) than
patients with less knowledge (domain1a: 1.5, p. =<.001;
domain2b:1.2; p =<.001).
Regarding the level of model fit, PBMS explained high
percentages of criterion variance for the intention to use
DMT. Depending on the predictor set PBMS explained be-
tween 41 and 50% at baseline and between 69 and 78% of
the variance after educational programme in the total sam-
ple (Table 2). All predictor sets showed higher percentages
of explained variance in the intervention group (IG) than
the control group (CG) (intention estimate: CG 56% / IG
69%, p= .179; three domains CG 56% / IG 74%, p= .047; six
sub-domains CG 64% / IG 78%, p= .073) (Table 2).
Using the PBMS to compare the relative influence of
TPB domains between the study groups led to ambiguous
results. The power to predict attitude was equal in the
intervention and control groups. Contrary to our assump-
tion the influence of subjective social norm appeared not
to be weakened by the intervention. However, perceived
behaviour control turned out to take on a greater rele-
vance in the decision making process after the interven-
tion. In other words, patients’ decisions became more
likely to reflect the belief that they had control over the
target behaviour and its consequences (Table 5).Discussion
This study aimed to develop a questionnaire to assess MS
patients’ cognitive and emotional representation of deci-
sion making processes regarding disease modifying treat-
ments (DMT) based on the theory of planned behaviour
(TPB). In pre-testing the questionnaire had already been
found to possess convincing item properties and feasibility
and encouraging indications of validity. The larger dataset
from the RCT yielded further support for the PBMS
measurement concept in various regards.
The PBMS was found to possess high predictive power
for the target criterion, intention to use DMT. This suggests
that the PBMS item pool fully covered the relevant beliefTable 5 Relative influence of PBMS domains






Attitude 49 45 .76
Subjective social norm 31 21 .51
Perceived behaviour control 63 50 .25
The table illustrates the predictive power of single domains separately for the
study groups. P values for differences between the percentages of explained
variance as drawn from regression analyses were calculated using Fishers Z-test.
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sion. PBMS also showed a good sensitivity to differences in
beliefs about DMT and the level of corresponding risk
knowledge. PBMS response patterns reflected the hypothe-
sised effects of an educational intervention providing factual
information about DMT, with responses indicating that the
intervention group subsequently showed a more critical at-
titude and less willingness to comply with social norms.
These results correspond with the programme’s underlying
aim of enabling patients to make decisions based on per-
sonal values and realistic beliefs about expected outcomes
in an area where most information is commercially driven.
It was expected that the patients’ ability to reflect on these
beliefs would be strengthened by providing evidence-based
patient information on DMT.
The PBMS showed substantial construct validity by
discriminating subgroups with differing DMT status (5
of six domains). Beyond the absolute PBMS score values,
the PBMS was also found to be sensitive to the decision
support intervention at the level of model fit. The pre-
dictive power of the PBMS was higher in the interven-
tion group than in the control group.
This effect is insightful as the basic idea of supporting
patients in processing evidence based patient information
is to enable patients to reflect on their own priorities when
making DMT decisions [28]. Our results showed the inter-
vention group to possess increased cognitive awareness of
the belief composites underpinning individual decisions.
Cognitive awareness, however, results from deeper elabor-
ation of scientific and internal motivational information
relevant to the decision [8]. The latter process complies
with evidence based medicine and decision support strat-
egies. These aim to enhance communication and informa-
tion processing by using decision aids, evidence based
patient information tools, educational programmes, and
shared decision making. Earlier work by our group showed
that, although it may not alter treatment choices, evidence-
based patient information can alter decision processes [21].
The results relating to possible shifts in the proportions by
which single domains impact on the intention remain am-
biguous in the present study. Proportional changes as
found in this study could reflect the dynamic character of
proportional impact of the TPB domains. However, this dy-
namic needs further investigation.
The study also has some limitations. First, the selection of
TPB out of a pool of more than 30 psychological theories of
behaviour change [29] can be challenged. Although evidence
for its applicability to various behaviours is substantial, TPB
and the rigorous structure of its components (e.g. expecta-
tions multiplying values) have been criticized for ascribing
too much importance to rational processes [14,30]. As well
as rational reasoning, emotional processes and routine be-
haviour (lacking any decision) also affect motivation when
deciding on a specific behaviour [14]. Regardless of thecurrent understanding that emotional processing is essential
for and effectively inseparable from cognitive appraisal, we
also think that emotional appraisal is adequately represented
within each of the sub-domains of our tool (Additional file
1). For instance, by formulating items such as “The risk I
would be taking by putting off immunotherapy for too long
frightens me.” we intended to address emotional aspects of
MS-patients’ belief system. On the other hand, the theory’s
emphasis on rationality was helpful in focusing on the
process of systematic and conscious reflection on the motiv-
ation in medical decision making. Our study results confirm
our rationale in this regard.
The questionnaire’s additive and multiplicative struc-
ture can be challenged for two further reasons. First, the
extent of possible hidden redundancy in the items’
underpinning constructs is not yet clear. Second, since
our multiple logistic regression analyses were limited to
main effects, we cannot exclude interaction effects, e. g
“knowledge of risks” may interact with “compliance with
norms”. Both would contradict the rigid algorithm to
achieve the component scores and the intention / behav-
iour estimate. However, automatic detection of interac-
tions would have required far greater sample sizes and
clear a priori hypotheses for specific interactions. For
this initial study we therefore considered it reasonable to
adhere to the strategy outlined by Ajzen [9,26]. The con-
version of an intention into action is determined not
only by the person’s intention but also by personal and
environmental barriers and by the person’s volitional
control. In this regard, our results have to be seen as
preliminary. However, we are awaiting data on DMT up-
take from the PEPADIP trial which will enable us to val-
idate the PBMS using the actual target behaviour rather
than a substitute. It can be argued that some of our
results could emerge by chance due to multiple testing.
Indeed, the study was not sufficiently powered to keep
all reported differences when using an alpha level
adjusted to a number of six tests conducted in parallel.
However, our testing was driven by clear hypotheses re-
ferring to the complete model. Moreover, as these hy-
potheses refer to a given fixed hierarchical structure,
multiplicity of the used parameters is limited. Similarity
of the results of pre-test and controlled trial provides
further support for their relevance. Finally, it was not
possible to employ a test-retest strategy to estimate
PBMS reliability because the control group showed con-
siderable change in some of the domains between pre-
and post-intervention. However, three and six months
follow up data are now available for the PBMS. Here, no
further change was detected, either for the control group
or for the total sample, and test-retest reliabilities were
satisfactory for all six domains (.74; .71; .79, 79; .60; .71)
based on 155 data sets. Further studies will be necessary
to replicate these results.
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http://www.biomedcentral.com/1472-6947/12/60Modeling behavioural decisions in terms of TPB con-
forms to basic assumptions of patient empowerment, since
it takes into account the social situation (subjective social
norm) and self-efficacy (control beliefs) as well as attitude.
Substantial evidence has shown the TPB to be helpful for
developing interventions motivating change of specific
health behaviours such as condom use, exercise, diet, and
medication adherence [11,18]. Our study is in agreement
with a number of other studies that have used TPB to eluci-
date inherent processes in individuals making health related
decisions [12-14,30]. When developing and evaluating the
effectiveness of theory based interventions, it is useful to be
able to identify specific underlying beliefs and measure their
impact on informed decision making. This is particularly
important, as better decisions, in terms of shared decision
making or the informed choice cannot (by definition) result
in immediate health improvement. Our study shows how
theory can be used to inform the design of an effective
intervention and to guide its evaluation. However, since the
TPB itself is generic and its domains are quite elementary,
we feel that it has great potential for developing specific
applications for other decision support contexts as well.
This would answer the call for more theoretical foundation
for decision support strategies [31,32]. Using the tool will
help us to further develop end-points for evaluation of pa-
tient empowerment and shared-decision making, for ex-
ample by making measures such as the Multimodal
Measure of Informed Choice more specific [3].
Conclusions
The study yielded first indicators for the validity of the
PBMS as a tool to provide fine grained analysis of inher-
ent processes in patients when making choices about
DMT. The questionnaire was sensitive to patients’
change in attitude and motivation to comply with social
norms evoked by an educational intervention. Moreover,
as reflected in the overall model fit, the questionnaire
also appeared to be sensitive to varying levels of depth
of decision elaboration. The use of the TPB as shown in
the development of the PBMS questionnaire is easily ap-
plicable to other decision making scenarios.
Additional file
Additional file 1: Appendix 1. English translation of the PBMS
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